Europe Home Infusion Therapy Market Size, Share & Trends Analysis Report By Type (Products, Services), By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Market Overview

An alternative to taking medication by mouth is infusion therapy, which is how the term is defined. The infusion process involves monitoring the administration of medication with the assistance of a sterile catheter inserted into a vein.

Home infusion therapy refers to giving an individual medication or biologicals through an intravenous or subcutaneous route while they live in their residence. The medication (such as antivirals or immune globulin, for example), the necessary piece of medical equipment (such as a pump), and the necessary medical supplies are required to carry out home infusion (for example, tubing and catheters). In a similar vein, nursing services are required to educate and train both the patient and the caregivers administering the infusion medications in the patient's home. Home infusion treatment frequently requires a significant contribution from visiting nurses. Typically, nurses will instruct the patient or the caregiver on how to self-administer the medication, educate the patient about the potential adverse effects of the treatment and the aims of therapy, and visit the patient occasionally to evaluate the infusion site and change the dressing. In most cases, the procedure of home infusion needs coordination among several different parties. These parties can include patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if necessary, home health organisations.

Market Dynamics

Drivers

The Growing Elderly Population & Increasing Demand for Long-Term Care

One of the significant drivers of the home infusion therapy market is the growing elderly population, prone to various severe disorders. The growing geriatric population and the rising prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea and vomiting are driving the trend. Because the virus is transmitted through physical contact, the COVID-19 outbreak increased the importance and demand for medical devices, particularly in a home-based setting.

The market for home infusion therapy in Europe is expected to grow significantly due to increased chronic disorders among individuals and growing government initiatives promoting the benefits of home infusion therapy. Furthermore, rising patient demand for long-term therapies is expected to drive market growth.

Two major factors are driving the market growth: the increasing geriatric population and an increase in disease burden are two significant factors driving the market growth. Furthermore, increased awareness has resulted in a greater preference for home infusion therapy among patients requiring long-term care, particularly the senior population.

Another driver of market growth is the well-established healthcare industry, easy access to healthcare needs, faster adoption of advanced technologies, and high disposable income of consumers. The availability of high-quality home infusion products for patients is also propelling the market growth.

Restraints

The Presence of A Complex Reimbursement Framework as Well as Reimbursement Cuts

One of the major factors driving the market growth is Medicare reimbursement for home healthcare providers and patients. Recent reimbursement cuts and rebasing of home health funding, on the other hand, are expected to impede market growth during the forecast period. Medicare proposed cutting home health funding by 3.5 per cent per year from 2014 to 2017 in its draught of the Home Health Prospective Payment System (HPPS) rule for 2014. This is expected to significantly impact home health funding and limit patients' and senior citizens' ability to access clinically advanced and cost-effective home-based care. Rebasing has resulted in lower average margins, which have fallen from 8.6 per cent in 2014 to 5.0 per cent in 2017. Furthermore, the elimination of 170 ICD-9 codes from home healthcare reimbursement policies is expected to limit market growth during the forecast period.

Europe Home Infusion Therapy Market Segmentation Analysis

By Type

The Europe Home Infusion Therapy Market is segmented into Products and Services. Products include infusion pumps, intravenous administration sets, IV cannulas, needleless connectors, and other medical consumables required for administering therapies in home settings, while services include nursing care, therapy management, patient education, monitoring, and clinical support. The growing preference for home-based healthcare, increasing prevalence of chronic diseases, aging populations, and the need to reduce hospital stays are supporting demand for both product and service offerings. Products form the essential equipment base for home infusion treatment, while services help ensure safe administration, treatment adherence, and appropriate patient monitoring outside traditional healthcare facilities.

Increasing healthcare costs, improvements in infusion technologies, expansion of home healthcare programs, and greater patient preference for receiving appropriate treatments at home are supporting market growth. Demand for products is driven by the need for reliable and portable infusion equipment and consumables, while services are gaining importance as healthcare providers seek to deliver coordinated clinical support for patients receiving long-term therapies. The expansion of outpatient care, increasing availability of trained home healthcare professionals, and growing use of remote monitoring technologies are expected to further support the adoption of home infusion therapy across Europe.

Request Customizationto receive a tailored report.

By Product

The Europe Home Infusion Therapy Market is segmented into Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. Infusion pumps enable controlled and accurate delivery of medications, fluids, and nutrients and are particularly useful for therapies requiring precise administration rates. Intravenous sets facilitate the delivery of infusion solutions from containers or pumps to patients, while IV cannulas provide vascular access for intravenous treatment. Needleless connectors allow safer connections between infusion components and can reduce the need for repeated needle access. Product selection depends on therapy requirements, treatment duration, patient condition, infusion volume, and clinical protocols.

Rising adoption of home-based treatment, increasing prevalence of chronic diseases, growing demand for portable medical technologies, and the expansion of home healthcare services are supporting demand across all product categories. Infusion pumps are gaining importance due to their ability to provide programmable and controlled administration, while intravenous sets, IV cannulas, and needleless connectors benefit from the growing number of patients requiring repeated or long-term infusion treatment. Continued product innovation, increasing emphasis on patient safety, and the need to simplify home-based therapy administration are expected to create further opportunities for infusion therapy product manufacturers across Europe.

By Application

The Europe Home Infusion Therapy Market is segmented into Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals. Anti-infective therapy is used for patients requiring prolonged intravenous treatment, while endocrinology applications include therapies requiring regular medication administration and monitoring. Hydration therapy supports patients who require fluid and electrolyte replacement, while selected chemotherapy treatments can be delivered in home settings under appropriate clinical supervision. Enteral and parenteral nutrition support patients who cannot obtain sufficient nutrition through normal oral intake, while specialty pharmaceuticals include complex therapies requiring specialized administration, monitoring, and patient support.

Rising prevalence of chronic diseases, increasing aging populations, growing demand for convenient treatment options, and efforts to reduce hospital utilization are supporting home infusion applications across Europe. Anti-infective treatments, hydration therapy, and nutritional applications are benefiting from the expansion of home healthcare, while specialty pharmaceuticals and selected chemotherapy applications are creating opportunities as healthcare systems develop more advanced home treatment programs. Increasing patient preference for appropriate care in familiar home environments, improvements in infusion technology, remote monitoring capabilities, and the availability of specialized healthcare professionals are expected to support continued adoption across these application areas.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The Europe home infusion therapy market is divided into the UK, Germany, France, Italy, and the Rest of Europe, based on country. According to the World Health Organization, Europe sees 3.7 million new cancer cases and 1.9 million cancer deaths each year, making it the second most common disease after heart disease. This has resulted in increased demand for physician-directed home infusions and related services, which is both cost-effective and less taxing on healthcare facilities.

List of Key and Emerging Players in Europe Home Infusion Therapy Market

• OMT GmbH & Co. KG
• Licher Medical Therapy (LMT)
• Sciensus
• Mediq
• Hala Altab Medical Car
• Enayati Home Health Care
• ORKYN
• ICU Medical
• JMS CO., LTD.
• Smiths' Medical, Inc.